Medipost Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
41,504
41,403
37,570
28,654
42,250
Cost of Goods Sold (COGS) incl. D&A
22,317
23,452
16,727
14,075
18,391
Gross Income
19,187
17,952
20,844
14,579
23,859
SG&A Expense
19,152
19,480
20,615
23,483
23,238
EBIT
200
1,775
211
9,319
66
Unusual Expense
776
701
4,048
44
4,257
Non Operating Income/Expense
141
1,013
2,190
123
382
Interest Expense
27
612
1,222
416
393
Pretax Income
1,317
2,177
1,366
7,805
3,626
Income Tax
190
368
3,239
2,275
2,180
Equity in Affiliates
-
-
826
162
-
Consolidated Net Income
1,127
1,809
2,698
5,368
1,446
Net Income
996
1,851
2,779
5,367
1,445
Net Income After Extraordinaries
996
1,851
2,779
5,367
1,445
Net Income Available to Common
996
1,851
2,779
5,367
1,445
EPS (Basic)
141.00
257.00
376.00
696.00
187.00
Basic Shares Outstanding
7
7
7
8
8
EPS (Diluted)
158.19
257.16
375.74
696.03
186.77
Diluted Shares Outstanding
7
7
7
8
8
EBITDA
2,597
1,379
4,542
4,594
4,559
Other Operating Expense
235
246
440
416
556
Non-Operating Interest Income
2,460
1,924
1,924
1,669
1,530
Minority Interest Expense
132
42
80
1
1
Equity in Affiliates (Pretax)
-
-
-
-
190

About Medipost Co.

View Profile
Address
21 Daewangpangyo-ro 644 beon-gil
Seongnam GY 13494
Korea, Republic Of
Employees -
Website http://www.medi-post.co.kr
Updated 09/14/2018
Medipost Co., Ltd. engages in the development and manufacture of stem cell biotechnology products. It operates through the following business divisions: Cord Blood Bank, Stem Cell Therapy, Health Functional Food, Import and Distribution of Natural Cosmetics and Healthcare Services. The Cord Blood Bank division is involved in collecting and storing stem cells from the newborn's umbilical cord.